MGI
GMAB icon

Miller Global Investments’s Genmab GMAB Stock Holding History

Miller Global Investments’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.12K Hold
77
– – ﹤0.01% 269
2026
Q1 		$2.07K Hold
77
– – ﹤0.01% 270
2025
Q4 		$2.37K Buy
+77
New +$2.4K ﹤0.01% 232

Other funds holding GMAB

Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
PL
Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
OAM
Oppenheimer Asset Management New York $9.63B AUM 30.32% 1-Year Est. Return
EGA
Eagle Global Advisors Houston, Texas $3.02B AUM 34.37% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return
LWAM
Legacy Wealth Asset Management Woodbury, Minnesota $456M AUM 35.19% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
TNAM
Terra Nova Asset Management New York $163M AUM 43.09% 1-Year Est. Return
Fifth Third Bancorp
Fifth Third Bancorp Cincinnati, Ohio $61.7B AUM 33.76% 1-Year Est. Return

Miller Global Investments's GMAB Position: Q2 2026 in Review

Miller Global Investments held its Genmab (GMAB) position steady in Q2 2026 at 77 shares worth $2.12K. The position accounts for ﹤0.01% of the portfolio, ranked #269.

Miller Global Investments first reported a position in GMAB in Q4 2025 and has held it in 3 quarters since. The position peaked at $2.37K in Q4 2025. 98 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Miller Global Investments held 77 shares of Genmab worth $2.12K as of Q2 2026.
  • Miller Global Investments left its Genmab share count unchanged in Q2 2026.
  • Genmab made up ﹤0.01% of Miller Global Investments's portfolio in Q2 2026, its #269 holding.
  • Miller Global Investments first reported a position in Genmab in Q4 2025 and has held it in 3 quarters since.
  • Miller Global Investments's Genmab position peaked at $2.37K in Q4 2025.
  • 98 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Miller Global Investments's 13F filing for Q2 2026, filed 1 Jul 2026.